Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Risk factors and efficacy of different intravitreal treatment options for symptomatic focal vitreomacular traction with or without full-thickness macular hole.

International ophthalmology·2025

Same author

[Effect of low-dose PDT on perfusion of the choriocapillaris in cCSCR : An OCT-angiography-based study].

Die Ophthalmologie·2021

Same author

[Bilateral subretinal fluid and pigmented deposits in a young female patient].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2021

Same author

[Large macular hole-Always a poor prognosis?]

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2020

Same author

[MEK inhibitor-associated retinopathy under binimetinib treatment for cutaneous malignant melanoma].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2020

Same author

[Real-time optical coherence tomography-assisted high-precision vitreoretinal surgery in the clinical routine].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2019

Search research articles

Related Experiment Video

Updated: May 9, 2026

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

[Vitreomacular Traction Syndrome (VMTS)].

M M Maier¹, N Feucht, S Burzer

¹Augenklinik, Klinikum rechts der Isar, Technische Universität München.

Klinische Monatsblatter Fur Augenheilkunde

|July 12, 2013

Summary

Vitreomacular traction syndrome (VMTS) involves persistent vitreoretinal adhesion causing vision loss. Pharmacological vitreolysis shows promise as a non-surgical treatment option for VMTS patients.

Area of Science:

Ophthalmology
Retinal Diseases
Vitreoretinal Interface Imaging

Context:

Vitreomacular traction syndrome (VMTS) is characterized by anomalous posterior vitreous detachment (APVD) and persistent vitreoretinal adhesion.
This adhesion can lead to macular thickening, macular edema, and reduced best-corrected visual acuity (BCVA).
Spectral domain optical coherence tomography (SD-OCT) provides detailed visualization of retinal microstructure and vitreoretinal interface abnormalities in VMTS.

Purpose:

To explore the potential of pharmacological vitreolysis as a treatment for VMTS.
To evaluate the therapeutic effects of vitreolysis in patients with symptomatic vitreoretinal adhesion and traction.

Summary:

VMTS presents with symptomatic vitreoretinal adhesion, causing macular edema and decreased visual acuity.

More Related Videos

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Whole Vitreous Humor Dissection for Vitreodynamic Analysis

Whole Vitreous Humor Dissection for Vitreodynamic Analysis

Published on: May 24, 2015

Related Experiment Videos

Last Updated: May 9, 2026

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Whole Vitreous Humor Dissection for Vitreodynamic Analysis

Whole Vitreous Humor Dissection for Vitreodynamic Analysis

Published on: May 24, 2015

While vitreoretinal surgery is the traditional treatment, recent studies indicate that pharmacological vitreolysis can be effective.

Pharmacological vitreolysis offers a potential non-surgical therapeutic approach for managing VMTS.

Impact:

These findings suggest a shift towards less invasive, pharmacological treatments for VMTS.
Pharmacological vitreolysis represents a significant advancement in the management of vitreoretinal adhesion and traction.
This research paves the way for future development of non-surgical interventions for VMTS.